Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples